Research Papers:
Precursor N-cadherin mediates glial cell line-derived neurotrophic factor-promoted human malignant glioma
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1495 views | HTML 2414 views | ?
Abstract
Ye Xiong1,*, Liyun Liu1,*, Shuang Zhu1, Baole Zhang1, Yuxia Qin1, Ruiqin Yao1, Hao Zhou2, Dian Shuai Gao1
1Department of Neurobiology and Anatomy, Xuzhou Key Laboratory of Neurobiology, Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China
2Key Laboratory of Industrial Ecology and Environmental Engineering (Ministry of Education), School of Food and Environmental, Dalian University of Technology, Panjin Campus, Panjin 124221, China
*These authors have contributed equally to this work
Correspondence to:
Dian Shuai Gao, email: [email protected]
Keywords: precursor N-cadherin, glioma cells, GDNF, migration, invasion
Received: July 20, 2016 Accepted: January 19, 2017 Published: February 12, 2017
ABSTRACT
As the most prevalent primary brain tumor, gliomas are highly metastatic, invasive and are characteristic of high levels of glial cell-line derived neurotrophic factor (GDNF). GDNF is an important factor for invasive glioma cell growth; however, the underlying mechanism involved is unclear. In this study, we affirm a significantly higher expression of the precursor of N-cadherin (proN-cadherin) in most gliomas compared with normal brain tissues. Our findings reveal that GDNF interacts with the extracellular domain of proN-cadherin, which suggests that proN-cadherin mediates GDNF-induced glioma cell migration and invasion. We hypothesize that proN-cadherin might cause homotypic adhesion loss within neighboring cells and at the same time promote heterotypic adhesion within the extracellular matrix (ECM) through a certain mechanism. This study also demonstrates that the interaction between GDNF and proN-cadherin activates specific intracellular signaling pathways; furthermore, GDNF promoted the secretion of matrix metalloproteinase-9 (MMP-9), which degrades the ECM via proN-cadherin. To reach the future goal of developing novel therapies of glioma, this study, reveals a unique mechanism of glioma cell migration and invasion.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15302